13-08-2026 16:59 via drugs.com

Therapeutic Hypothermia Duration Explored in Comatose OHCA Survivors

THURSDAY, Aug. 13, 2026-- For comatose survivors of out-of-hospital cardiac arrest treated with therapeutic hypothermia, neurological outcomes are not improved with increasing cooling duration, according to a study published online Aug. 5 in the...
Read more »

Pharmaceutical Industry news



Stair Climbing Associated With Reduction in Cardiovascular, All-Cause Mortality
Socioeconomic Inequalities Tied to Functional Aging
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay
First Metatarsophalangeal Joint Arthrodesis Eases Painful Hallux Rigidus
Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease
Study IDs Neurobiological Roots of Sensory Over-Responsivity
2005 to 2023 Saw Decrease in DXA Testing for Osteoporosis Screening
Endometriosis Tied to Higher Risk for Developing Type 2 Diabetes
Older Adults Limit Movements With Rising Temperatures
Physician Normalization of Symptoms May Lead Patients to Not Seek Treatment
Subclinical Cardiac Dysfunction Linked to Neurodegeneration in APOE-ε4 Carriers
Dexamethasone Eye Drops Can Reduce Progression to ROP Requiring Treatment
Deramiocel Can Safely Slow Progression in Advanced Duchenne Muscular Dystrophy
AMH Predicts Benefit of Chemo + Endocrine Therapy in Under 55s With Breast Cancer
Desktop versie